
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
Mohamed E. Abdallah, Mahmoud Zaki El-Readi, Mohammad Althubiti, et al.
Molecules (2020) Vol. 25, Iss. 15, pp. 3355-3355
Open Access | Times Cited: 30
Mohamed E. Abdallah, Mahmoud Zaki El-Readi, Mohammad Althubiti, et al.
Molecules (2020) Vol. 25, Iss. 15, pp. 3355-3355
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Le Yu, Jessica Wei, Pengda Liu
Seminars in Cancer Biology (2021) Vol. 85, pp. 69-94
Closed Access | Times Cited: 352
Le Yu, Jessica Wei, Pengda Liu
Seminars in Cancer Biology (2021) Vol. 85, pp. 69-94
Closed Access | Times Cited: 352
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
Salima Akter, Md. Ataur Rahman, Mohammad Nazmul Hasan, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 650-650
Open Access | Times Cited: 62
Salima Akter, Md. Ataur Rahman, Mohammad Nazmul Hasan, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 650-650
Open Access | Times Cited: 62
Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle
Mahmoud Zaki El-Readi, Majed Abdurhman Abdulkarim, Ahmed A. H. Abdellatif, et al.
Drug Development and Industrial Pharmacy (2024), pp. 1-15
Closed Access | Times Cited: 8
Mahmoud Zaki El-Readi, Majed Abdurhman Abdulkarim, Ahmed A. H. Abdellatif, et al.
Drug Development and Industrial Pharmacy (2024), pp. 1-15
Closed Access | Times Cited: 8
Survivin (BIRC5): Implications in cancer therapy
Giuseppe Siragusa, Laura Tomasello, Carla Giordano, et al.
Life Sciences (2024) Vol. 350, pp. 122788-122788
Open Access | Times Cited: 7
Giuseppe Siragusa, Laura Tomasello, Carla Giordano, et al.
Life Sciences (2024) Vol. 350, pp. 122788-122788
Open Access | Times Cited: 7
Enhanced Anti-Cancer Potential: Investigating the Combined Effects with Coriolus versicolor Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro
Tomasz Jędrzejewski, Justyna Sobocińska, Bartosz Maciejewski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1556-1556
Open Access
Tomasz Jędrzejewski, Justyna Sobocińska, Bartosz Maciejewski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1556-1556
Open Access
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
Mahmoud Zaki El-Readi, Ahmed M. Al‐Abd, Mohammad Althubiti, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Mahmoud Zaki El-Readi, Ahmed M. Al‐Abd, Mohammad Althubiti, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
Ashraf N. Abdalla, Amal Qattan, Waleed H. Malki, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4606-4606
Open Access | Times Cited: 27
Ashraf N. Abdalla, Amal Qattan, Waleed H. Malki, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4606-4606
Open Access | Times Cited: 27
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
Adrian Zając, Joanna Sumorek-Wiadro, Ewa Langner, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5155-5155
Open Access | Times Cited: 26
Adrian Zając, Joanna Sumorek-Wiadro, Ewa Langner, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5155-5155
Open Access | Times Cited: 26
Tamoxifen and oxidative stress: an overlooked connection
Nermin S. Ahmed, Marek Samec, Alena Líšková, et al.
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Nermin S. Ahmed, Marek Samec, Alena Líšková, et al.
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 24
The Role of Bcl-2 and Beclin-1 Complex in “Switching” between Apoptosis and Autophagy in Human Glioma Cells upon LY294002 and Sorafenib Treatment
Adrian Zając, Aleksandra Maciejczyk, Joanna Sumorek-Wiadro, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2670-2670
Open Access | Times Cited: 9
Adrian Zając, Aleksandra Maciejczyk, Joanna Sumorek-Wiadro, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2670-2670
Open Access | Times Cited: 9
Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
Lijuan Zhang, Yuxuan Zhu, Jiahui Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Lijuan Zhang, Yuxuan Zhu, Jiahui Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Influences of cold atmospheric plasma on apoptosis related molecules in osteoblast-like cells in vitro
Benedikt Eggers, Jana Marciniak, Svenja Memmert, et al.
Head & Face Medicine (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 13
Benedikt Eggers, Jana Marciniak, Svenja Memmert, et al.
Head & Face Medicine (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 13
β-carboline compound-10830733 suppresses the progression of non-small cell lung cancer by inhibiting the PI3K/Akt/GSK 3β signaling pathway
Fangrui Lin, Junmin Shen, Hangyu Li, et al.
European Journal of Pharmacology (2024), pp. 177131-177131
Closed Access | Times Cited: 1
Fangrui Lin, Junmin Shen, Hangyu Li, et al.
European Journal of Pharmacology (2024), pp. 177131-177131
Closed Access | Times Cited: 1
Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin
Ashraf N. Abdalla, Miriana Di Stefano, Giulio Poli, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 90-90
Open Access | Times Cited: 12
Ashraf N. Abdalla, Miriana Di Stefano, Giulio Poli, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 90-90
Open Access | Times Cited: 12
Drug Repurposing by Tumor Tissue Editing
Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Targeting nutrient metabolism with FDA-approved drugs for cancer chemoprevention: Drugs and mechanisms
Yifei Xie, Ke Yao, Zigang Dong, et al.
Cancer Letters (2021) Vol. 510, pp. 1-12
Closed Access | Times Cited: 9
Yifei Xie, Ke Yao, Zigang Dong, et al.
Cancer Letters (2021) Vol. 510, pp. 1-12
Closed Access | Times Cited: 9
High Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Correlating the Metabolic Changes of Lactate, Pyruvate and L-Glutamine with Induced Tamoxifen Resistant MCF-7 Cell Line Potential Molecular Changes
Ala A. Alhusban, Sokiyna Albustanji, Lama Hamadneh, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4824-4824
Open Access | Times Cited: 9
Ala A. Alhusban, Sokiyna Albustanji, Lama Hamadneh, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4824-4824
Open Access | Times Cited: 9
Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents
Jianqing Zhang, Hehua Xiong, Feiyi Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 33, pp. 127740-127740
Closed Access | Times Cited: 8
Jianqing Zhang, Hehua Xiong, Feiyi Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 33, pp. 127740-127740
Closed Access | Times Cited: 8
Investigating the molecular mechanisms of Tamoxifen on the EMT pathway among patients with breast cancer
Mohammadhossein Mirzaei, Seyed Amir Sheikholeslami, Arsalan Jalili, et al.
Journal of Medicine and Life (2022) Vol. 15, Iss. 6, pp. 835-844
Open Access | Times Cited: 4
Mohammadhossein Mirzaei, Seyed Amir Sheikholeslami, Arsalan Jalili, et al.
Journal of Medicine and Life (2022) Vol. 15, Iss. 6, pp. 835-844
Open Access | Times Cited: 4
Antiproliferative activity of Tamoxifen, Vitamin D3 and their concomitant treatment.
Derya Yetkin, Ebru Ballı, Furkan Ayaz
PubMed (2021)
Closed Access | Times Cited: 5
Derya Yetkin, Ebru Ballı, Furkan Ayaz
PubMed (2021)
Closed Access | Times Cited: 5
Proteomic Analysis Reveals Major Proteins and Pathways That Mediate the Effect of 17-β-Estradiol in Cell Division and Apoptosis in Breast Cancer MCF7 Cells
Zhenqi Zhou, Brihget Sicairos, Jianhong Zhou, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 11, pp. 4835-4848
Open Access
Zhenqi Zhou, Brihget Sicairos, Jianhong Zhou, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 11, pp. 4835-4848
Open Access
Design and Synthesis of Luteinizing Hormone Releasing Hormone (Lhrh)-Derived Peptide Conjugates with Pi3k Inhibitor for Enhanced Tumor Selectivity
Chenyu Zhang, Zhong Hong-lan, Xiang Li, et al.
(2024)
Closed Access
Chenyu Zhang, Zhong Hong-lan, Xiang Li, et al.
(2024)
Closed Access
Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis and Survival Outcomes
A. J. Clark, Rajesh Singh, Regina Leonis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12356-12356
Open Access
A. J. Clark, Rajesh Singh, Regina Leonis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12356-12356
Open Access